2027 Y-Site Compatibility of Critical Care Admixtures Wall Chart
PURCHASE ORDERS: Please fax your PO to 707.257.7566 or send via email to info@kingguide.com.
Ships in November 2026 - Order now and we will ship your order as soon as we receive them from the printing press.
The 2027 King Guide Y-Site Compatibility of Critical Care Admixtures Wall Chart reports on the compatibility of IV drugs commonly administered to patients in a critical care setting and includes antibiotics, vitamins, tpn and other drugs.
Identify FDA Boxed Warning Drugs
Report Infusion Fluid Compatibility for 4 infusion fluids (D5W, D5½S, Lactated Ringer's, and Normal Saline)
This 27" x 27" poster is laminated and includes compatibility of 122 drugs and 4 infusion fluids updated with new data that has appeared in the complete King® Guide to Parenteral Admixtures® throughout 2026.
NOTE: Laminated charts may be required in hospitals by some state inspectors.
For 2027 we updated y-site compatibility for:
- Amikacin Sulfate
- Amphotericin B
- Calcium Chloride
- Cefotaxime Sodium
- Ceftriaxone Sodium
- Diazepam
- Dobutamine Hydrochloride
- Fentanyl Citrate
- Furosemide
- Meropenem
- Midazolam Hydrochloride
- Nalbuphine Hydrochloride
- Norepinephrine Bitartrate
- Ondansetron Hydrochloride
- Pantoprazole Sodium
- Piperacillin and Tazobactam
- Sodium Bicarbonate
- Vancomycin Hydrochloride
Need more injectable drug compatibility & stability information?
Full text monographs for over 600 injectable drugs from over 3400 peer-reviewed, primary source references are available in the complete King® Guide to Parenteral Admixtures®.
More Information:
Internet Edition
